IP Library Granted Patent US 8,524,882
Granted Patent B2
US 8,524,882 · App. 13/152,907 · Granted Sep 3, 2013

Method for deblocking of labeled oligonucleotides

Inventors: Gulilat Gebeyehu (Potomac, MD); Richard Pires (Mount Airy, MD)
Assignee: Life Technologies Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,524,882
App. No.
13/152,907
Granted
Sep 3, 2013
Kind
B2
Abstract

The invention relates to a process for deblocking substantially a blocked, detectably labeled oligonucleotide by contacting the blocked detectably labeled oligonucleotide with an effective amount of a nucleophilic amino compound under conditions that result in substantial deblocking of the oligonucleotide, thereby giving the substantially deblocked oligonucleotide.

Claims (20)

1. A process for deblocking substantially a blocked, detectably labeled oligonucleotide comprising contacting the blocked detectably labeled oligonucleotide with an effective amount of a nucleophilic amino compound in the presence of one or more carbohydrates and/or sugars under conditions that result in the deblocking of the oligonucleotide, thereby giving the substantially deblocked oligonucleotide.

2. The process of claim 1 , wherein said detectable label is a fluorescent label.

3. The process of claim 1 , wherein said nucleophilic amino compound is ammonia.

4. The process of claim 3 , wherein said ammonia is present at a psi of about 20 to 200.

5. The process of claim 3 , wherein said ammonia is present at a psi of about 80.

6. The process of claim 1 , wherein said nucleophilic amino compound is ammonia vapors.

7. The process of claim 1 , wherein said nucleophilic amino compound is a C 1-6 alkylamine.

8. The process of claim 1 , further comprising dissolving the substantially deblocked oligonucleotide in a buffer.

9. The process of claim 1 , wherein said conditions comprise carrying the process at about room temperature to about 150° C.

10. The process of claim 1 , wherein said conditions comprise carrying out the process at about 95° C.

11. The process of claim 1 , wherein said conditions comprise carrying out the process for about 1 min to about 2 hrs.

12. The process of claim 1 , wherein said substantially blocked, detectably labeled oligonucleotide is immobilized on a solid phase.

13. The process of claim 12 , wherein said substantially deblocked oligonucleotide is cleaved from said solid phase under said conditions.

14. A process for deblocking substantially a blocked, detectably labeled oligonucleotide comprising contacting the blocked detectably labeled oligonucleotide with an effective amount of ammonia saturated with water vapor at about 80 psi, 95° C., for about 45 min, thereby giving the substantially deblocked oligonucleotide.

15. The process of claim 14 , wherein said blocked, detectably labeled oligonucleotide is immobilized on a solid phase.

16. The process of claim 15 , wherein said substantially deblocked oligonucleotide is released cleaved from said solid phase.

17. A composition comprising a blocked, detectably labeled oligonucleotide and an effective amount of a nucleophilic amino compound sufficient to deblock substantially said oligonucleotide and one or more carbohydrates and/or sugars.

18. The composition of claim 17 , wherein said detectable label is a fluorescent label.

19. The composition of claim 17 , wherein said nucleophilic amino compound is ammonia.

20. The composition of claim 17 , wherein said nucleophilic amino compound is ammonia vapors.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2015
From: GEBEYEHU, GULILAT; PIRES, RICHARD
To: LIFE TECHNOLOGIES INC.
Reel/Frame 035021/0459 →
MERGER Recorded Feb 24, 2015
From: LIFE TECHNOLOGIES INC.
To: INVITROGEN CORPORATION
Reel/Frame 035021/0467 →
MERGER Recorded Aug 15, 2013
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 031019/0792 →
Continuity (4)
Continuation 10365644 · Feb 13, 2003
Continuation 09576555 · May 24, 2000
Provisional Application 60135848 · May 24, 1999
Related Publication 20120253028A1 · Oct 4, 2012